Company Filing History:
2 out of 272 
2 out of 59 
Years Active: 2014-2016
Title: The Innovations of Sandra Rickert
Introduction
Sandra Rickert is a notable inventor based in Encinitas, California. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to her name, her work has implications for the treatment and understanding of poxvirus infections.
Latest Patents
Rickert's latest patents include the invention of Vaccinia virus H3L and B5R specific monoclonal antibodies and methods of making and using the same. This invention relates to antibodies and subsequences that specifically bind to the poxvirus B5R envelope protein, as well as antibodies that bind to the poxvirus H3L envelope protein. The combination of these antibodies offers potential advancements in therapeutic applications.
Career Highlights
Throughout her career, Sandra Rickert has worked with prominent organizations such as Kyowa Hakko Kirin Co., Limited and the La Jolla Institute for Allergy and Immunology. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Shinichiro Kato and Steve Granger. Their collaborative efforts have furthered the understanding of monoclonal antibodies and their applications in medicine.
Conclusion
Sandra Rickert's innovative work in the field of biotechnology, particularly with monoclonal antibodies, showcases her dedication to advancing medical science. Her contributions are significant and continue to impact the field positively.